Guobang Pharma Ltd (605507) — Free Cash Flow Generation Index
Guobang Pharma Ltd (605507) has a Free Cash Flow Generation Index of 0.64x as of September 2025. Free cash flow of CN¥200.68 Million represents 1% of operating cash flow (CN¥311.27 Million). Explore Guobang Pharma Ltd (605507) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guobang Pharma Ltd Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Guobang Pharma Ltd across 8 annual periods. For the full cash flow conversion analysis, see Guobang Pharma Ltd (605507) cash conversion ratio.
Annual Free Cash Flow Generation for Guobang Pharma Ltd (2017–2025)
Year-by-year Free Cash Flow Generation Index for Guobang Pharma Ltd. Check Guobang Pharma Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | CN¥281.57 Million | CN¥559.28 Million | CN¥277.71 Million | ▲ +23.8% |
| 2024 | 0.41x | CN¥287.29 Million | CN¥706.41 Million | CN¥419.12 Million | ▲ +190.7% |
| 2023 | -0.45x | CN¥-231.68 Million | CN¥516.76 Million | CN¥748.44 Million | ▼ -313.2% |
| 2022 | 0.21x | CN¥213.92 Million | CN¥1.02 Billion | CN¥803.12 Million | ▼ -34.8% |
| 2020 | 0.32x | CN¥247.55 Million | CN¥767.70 Million | CN¥520.16 Million | ▲ +186.5% |
| 2019 | -0.37x | CN¥-164.32 Million | CN¥440.86 Million | CN¥605.18 Million | ▼ -153.3% |
| 2018 | 0.70x | CN¥378.44 Million | CN¥541.68 Million | CN¥163.24 Million | ▲ +582.3% |
| 2017 | -0.14x | CN¥-21.44 Million | CN¥148.03 Million | CN¥169.48 Million | — |